New implant could replace eye drops after corneal surgery

NCT ID NCT06235567

ENROLLING_BY_INVITATION Disease control Sponsor: Maanasa Indaram, MD Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a tiny steroid-releasing implant (Dextenza) placed in the tear duct works as well as standard steroid eye drops after corneal crosslinking surgery for keratoconus. About 20 people aged 13 and older with progressive keratoconus will receive either the implant or drops. The goal is to reduce inflammation and improve recovery, especially for those who struggle with using eye drops multiple times a day.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KERATOCONUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

keratoconus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KERATOCONUS

Contacts and locations

Show contact details

Locations

Mission Bay Hospital

San Francisco, California, 94158, United States
UCSF Pediatric Ophthalmology

San Francisco, California, 94158, United States
Wayne and Gladys Center for Vision

San Francisco, California, 94158, United States